Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS

Ellen M. Tedaldi; Katherine Huppler Hullsiek; Carlos D. Malvestutto; Roberto C. Arduino; Evelyn J. Fisher; Paul J. Gaglio; Elizabeth R. Jenny-Avital; Joseph P. McGowan; George Perez

doi:10.1086/374841

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS

Ellen M. Tedaldi, Katherine Huppler Hullsiek, Carlos D. Malvestutto, Roberto C. Arduino, Evelyn J. Fisher, Paul J. Gaglio, Elizabeth R. Jenny-Avital, Joseph P. McGowan, George Perez

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline prevalence of HIV-HCV coinfection was positively associated with history of injection drug use, older age, antiretroviral therapy naive status, African American or Latino ethnicity, and no history of having sex with men. No association was found with baseline CD4⁺ cell count or HIV RNA level. The prevalence of HCV coinfection in a diverse HIV clinical trials cohort provides additional information about risk behaviors and demographic factors that can be used in the analysis of clinical and virologic outcomes.

Original language	English (US)
Pages (from-to)	1313-1317
Number of pages	5
Journal	Clinical Infectious Diseases
Volume	36
Issue number	10
DOIs	https://doi.org/10.1086/374841
State	Published - May 15 2003
Externally published	Yes

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1086/374841

Cite this

Tedaldi, E. M., Huppler Hullsiek, K., Malvestutto, C. D., Arduino, R. C., Fisher, E. J., Gaglio, P. J., Jenny-Avital, E. R., McGowan, J. P., & Perez, G. (2003). Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases, 36(10), 1313-1317. https://doi.org/10.1086/374841

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS. / Tedaldi, Ellen M.; Huppler Hullsiek, Katherine; Malvestutto, Carlos D. et al.
In: Clinical Infectious Diseases, Vol. 36, No. 10, 15.05.2003, p. 1313-1317.

Research output: Contribution to journal › Article › peer-review

Tedaldi, EM, Huppler Hullsiek, K, Malvestutto, CD, Arduino, RC, Fisher, EJ, Gaglio, PJ, Jenny-Avital, ER, McGowan, JP & Perez, G 2003, 'Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS', Clinical Infectious Diseases, vol. 36, no. 10, pp. 1313-1317. https://doi.org/10.1086/374841

@article{d3c5d22df29d4a1fa3e81876bf0ab8f9,

title = "Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS",

abstract = "The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline prevalence of HIV-HCV coinfection was positively associated with history of injection drug use, older age, antiretroviral therapy naive status, African American or Latino ethnicity, and no history of having sex with men. No association was found with baseline CD4+ cell count or HIV RNA level. The prevalence of HCV coinfection in a diverse HIV clinical trials cohort provides additional information about risk behaviors and demographic factors that can be used in the analysis of clinical and virologic outcomes.",

author = "Tedaldi, {Ellen M.} and {Huppler Hullsiek}, Katherine and Malvestutto, {Carlos D.} and Arduino, {Roberto C.} and Fisher, {Evelyn J.} and Gaglio, {Paul J.} and Jenny-Avital, {Elizabeth R.} and McGowan, {Joseph P.} and George Perez",

year = "2003",

month = may,

day = "15",

doi = "10.1086/374841",

language = "English (US)",

volume = "36",

pages = "1313--1317",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group

T2 - The Terry Beirn Community Programs for Clinical Research on AIDS

AU - Tedaldi, Ellen M.

AU - Huppler Hullsiek, Katherine

AU - Malvestutto, Carlos D.

AU - Arduino, Roberto C.

AU - Fisher, Evelyn J.

AU - Gaglio, Paul J.

AU - Jenny-Avital, Elizabeth R.

AU - McGowan, Joseph P.

AU - Perez, George

PY - 2003/5/15

Y1 - 2003/5/15

N2 - The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline prevalence of HIV-HCV coinfection was positively associated with history of injection drug use, older age, antiretroviral therapy naive status, African American or Latino ethnicity, and no history of having sex with men. No association was found with baseline CD4+ cell count or HIV RNA level. The prevalence of HCV coinfection in a diverse HIV clinical trials cohort provides additional information about risk behaviors and demographic factors that can be used in the analysis of clinical and virologic outcomes.

AB - The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline prevalence of HIV-HCV coinfection was positively associated with history of injection drug use, older age, antiretroviral therapy naive status, African American or Latino ethnicity, and no history of having sex with men. No association was found with baseline CD4+ cell count or HIV RNA level. The prevalence of HCV coinfection in a diverse HIV clinical trials cohort provides additional information about risk behaviors and demographic factors that can be used in the analysis of clinical and virologic outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0038750648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038750648&partnerID=8YFLogxK

U2 - 10.1086/374841

DO - 10.1086/374841

M3 - Article

C2 - 12746778

AN - SCOPUS:0038750648

SN - 1058-4838

VL - 36

SP - 1313

EP - 1317

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this